Christopher R. Fenimore - SVP Finance & CFO at Regeneron Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
SVP Finance & CFO
Stock Symbol
REGN on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Christopher R. Fenimore - trading volume in the past year for Regeneron Pharmaceuticals, Inc.

Holdings reported by Christopher R. Fenimore for Regeneron Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 16.3K $11.9M $730.81 Dec 16, 2024 Direct
Common Stock 1.9K $1.39M $730.81 Dec 16, 2024 By Trust
Common Stock 1.52K $1.11M $730.81 Dec 16, 2024 By 401(k) Plan
Common Stock 25 $18.3K $730.81 Dec 16, 2024 by Trust for Daugh
Common Stock 25 $18.3K $730.81 Dec 16, 2024 by Trust for Son
Non-Qualified Stock Option (right to buy) 9.98K Dec 6, 2024 Direct Common Stock
Non-Qualified Stock Option (right to buy) 0 Jan 23, 2024 Direct Common Stock

Transactions reported by Christopher R. Fenimore for Regeneron Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.